BioLizard Launches BioReflect Scientific Literature Search Platform
State-of-the-art machine learning assists in scientific literature search
Ghent, Belgium, 18 February 2021 – BioLizard, a bioinformatics and AI solutions company, today announced the launch of BioReflect, a flexible literature search platform for biosciences. Using BioReflect, researchers are able to conduct a complete literature search to find the publications most relevant to their research faster than using traditional search tools. After uploading a list of genes and/or proteins of interest, results are provided in an at-a-glance global overview, using topic-based clustering and including the integration of human disease annotations.
BioReflect uses state-of-the-art natural language processing and dimension reduction techniques to group publications by their content. This automated clustering provides researchers with immediate insight into the content of thousands of publications and helps them select the most interesting ones, allowing extrapolation to new hypotheses. “Conventional literature searches are long, laborious and frustrating exercises. Even then, the results are often not complete, meaning additional work is needed to obtain all information on a new gene or protein,” said Dr. Liesbeth Ceelen, general manager of BioLizard.
“Conventional literature searches are long, laborious, and frustrating exercises. Even then, the results are often not complete, meaning additional work is needed to obtain all information on a new gene or protein”
Dr. Alexander Koch, the lead developer of BioReflect, added “With BioReflect, researchers are able to quickly find all relevant information on one or more genes, clustered by content, it’s Google for biotech!“ We believe this tool will save time and resources in the everyday workflow for scientists.”
About BioLizard
BioLizard NV leverages its expertise in bioinformatics, biostatistics, artificial intelligence, and software development to solve the most challenging questions in biology and deliver solutions to clients. By combining expertise from diverse backgrounds, BioLizard provides a complete solution to its client – from data analysis to system integration and the development of an AI-aided interpretation system. The company was founded by Novalis Biotech Incubation. For more information visit www.lizard.bio.
Contact: Liesbeth Ceelen, general manager, BioLizard ? contact@lizard.bio
Related news
The first step in the journey from imprecise drug therapy to precision medicine – REPO4EU
BioLizard is proud to join the REPO4EU consortium.
Read more
BioLizard is now an Official Illumina Connected Analytics Implementation Partner
BioLizard is recognised as a skilled and competent service partner for ICA users.
Read more
BioLizard enters into a strategic partnership with flanders.bio
We’re proud to officially announce that BioLizard begins its strategic partnership with flanders.bio.
Read more
BioLizard partners up with AutoML provider JADBio
BioLizard partners with JADBio, a leading provider of automated machine learning (AutoML) tools.
Read more